- Home
- VRAX vs FOXO Comparison
VRAX vs FOXO Comparison
Compare VRAX & FOXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAX
- FOXO
- Stock Information
- Founded
- VRAX 2013
- FOXO 2019
- Country
- VRAX United Kingdom
- FOXO United States
- Employees
- VRAX N/A
- FOXO N/A
- Industry
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- FOXO Retail: Computer Software & Peripheral Equipment
- Sector
- VRAX Health Care
- FOXO Technology
- Exchange
- VRAX Nasdaq
- FOXO Nasdaq
- Market Cap
- VRAX 7.8M
- FOXO 8.0M
- IPO Year
- VRAX 2022
- FOXO N/A
- Fundamental
- Price
- VRAX $2.37
- FOXO $0.32
- Analyst Decision
- VRAX
- FOXO
- Analyst Count
- VRAX 0
- FOXO 0
- Target Price
- VRAX N/A
- FOXO N/A
- AVG Volume (30 Days)
- VRAX 198.4K
- FOXO 9.1M
- Earning Date
- VRAX 02-05-2025
- FOXO 11-19-2024
- Dividend Yield
- VRAX N/A
- FOXO N/A
- EPS Growth
- VRAX N/A
- FOXO N/A
- EPS
- VRAX N/A
- FOXO N/A
- Revenue
- VRAX $84,872.00
- FOXO $1,341,000.00
- Revenue This Year
- VRAX $5,169.18
- FOXO N/A
- Revenue Next Year
- VRAX $66.97
- FOXO N/A
- P/E Ratio
- VRAX N/A
- FOXO N/A
- Revenue Growth
- VRAX 7.03
- FOXO 196.03
- 52 Week Low
- VRAX $0.60
- FOXO $0.13
- 52 Week High
- VRAX $9.00
- FOXO $1.30
- Technical
- Relative Strength Index (RSI)
- VRAX 64.60
- FOXO 39.05
- Support Level
- VRAX $1.51
- FOXO $0.43
- Resistance Level
- VRAX $1.98
- FOXO $0.53
- Average True Range (ATR)
- VRAX 0.18
- FOXO 0.06
- MACD
- VRAX 0.03
- FOXO -0.03
- Stochastic Oscillator
- VRAX 98.85
- FOXO 7.76
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
About FOXO FOXO Technologies Inc.
FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.